Gay men can now donate blood after FDA changes decades-old rule – a health policy researcher explains the benefits

In 1983, during the early days of the AIDS epidemic, the US Food and Drug Administration made the decision to ban gay men from donating blood. Now, 40 years later, it is dropping that rule.

Ayako Miyashita, Adjunct Professor of Public Policy and Social Welfare, University of California, Los Angeles • conversation
May 16, 2023 ~6 min

Biden's strategy for cutting carbon emissions from electricity generation could extend the lives of fossil fuel power plants

After the Supreme Court overturned the Obama administration’s strategy for reducing power plant carbon emissions in 2022, the Biden administration is taking a narrower but still ambitious approach.

Jennifer K. Rushlow, Dean, Vermont School for the Environment, and Professor of Law, Vermont Law & Graduate School • conversation
May 12, 2023 ~9 min


What is carbon capture and storage? EPA’s new power plant standards proposal gives it a boost, but CCS is not a quick solution

Carbon capture and storage could keep gas and coal-fired power plants running under newly proposed federal emissions standards, but it faces high hurdles.

Soyoung Oh, Junior Research Fellow in Climate Policy, The Fletcher School, Tufts University • conversation
May 11, 2023 ~7 min

What is carbon capture and storage? EPA’s new power plant standards proposal gives CCS a boost, but it’s not a quick solution

Carbon capture and storage could keep gas and coal-fired power plants running under newly proposed federal emissions standards, but it faces high hurdles.

Soyoung Oh, Junior Research Fellow in Climate Policy, The Fletcher School, Tufts University • conversation
May 11, 2023 ~7 min

What is carbon capture and storage? Power plant CCS gets a boost with EPA’s proposed new rules, but it's not a quick solution

Carbon capture and storage is the most promising solution for gas and coal-fired power plants to keep running under the proposed new regulations, but it faces high hurdles.

Soyoung Oh, Junior Research Fellow in Climate Policy, The Fletcher School, Tufts University • conversation
May 11, 2023 ~7 min

FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.

Annette Regan, Associate Professor of Epidemiology, University of San Francisco • conversation
May 10, 2023 ~7 min

These four challenges will shape the next farm bill – and how the US eats

Even if you don’t live near farm country, you’ve got a stake in the upcoming farm bill – including what kind of farms your tax dollars support.

Kathleen Merrigan, Executive Director, Swette Center for Sustainable Food Systems, Arizona State University • conversation
May 8, 2023 ~10 min

Mifepristone is under scrutiny in the courts, but it has been used safely and effectively around the world for decades

Mifepristone’s safety in medication abortions has been well established over more than two decades, but legal wrangling leaves the future of the drug hanging in the balance.

Grace Shih, Associate Professor of Family Medicine, School of Medicine, University of Washington • conversation
April 26, 2023 ~8 min


Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo

As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.

Christine Coughlin, Professor of Law, Wake Forest University • conversation
April 26, 2023 ~9 min

How will the Supreme Court's decision on mifepristone affect abortion access? 4 questions answered

The Supreme Court’s ruling on mifepristone keeps the drug accessible for now, but its future is still in limbo.

Tami S. Rowen, Associate Professor of Obstetrics, Gynecology and Gynecologic Surgery, University of California, San Francisco • conversation
April 24, 2023 ~10 min

/

32